The UK's National Health Service drug bill (hospital and community) has declined as a proportion of overall NHS spending from 12.7% in 1999 to 11% in 2005, according to research published by the Office of Health Economics, a consultancy that is part of the Association of the British Pharmaceutical Industry. In total, the NHS drugs bill was L10.54 billion ($20.69 billion).
The data, published in the 2007 edition of the OHE's annual Compendium of Health Statistics, was calculated from a range of sources, including the government's Prescription Pricing Authority.
The volume of drug prescriptions dispensed rose from 616 million in 1997 to 881 million in 2005, an increase of 35%. The rising cost of newer drugs is reflected in the average price per item over the same period: climbing 27%, from L8.77 to L11.13.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze